TOP NEWS

Illumina's GRAIL Raises $900M In Funding Round

GRAIL, the cancer detection spinout of San Diego's Illumina, said this morning that it has raised $900M in a first close of a planned, $1 billion funding round. The Series B funding was led by Arch Venture Partners, and included Johnson and Johnson Innovation, Amazon, Bristol-Myers Squibb, Celgene, McKesson Ventures, Merck, Tencent Holdings, and Varian Medical Systems. Illumina spun out GRAIL last year. GRAIL is based in Silicon Valley.


RELATED COMPANIES


RELATED STORIES

MARKETPLACE

LATEST HEADLINES

More Headlines

BROWSE ISSUES